• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Cosmetic Raw Material
  • Pharmaceutical IntermediatesPharmaceutical intermediates Nutritional Supplements Pharmaceutical raw materials
  • OEM & ODMCapsule Softgel Capsule Gummies Drop & drinks Tables
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Anthelmintics Antiviral drugs Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Cabozantinib Malate CAS 1140909-48-3 Raw Materials Powder

    • Cabozantinib Malate CAS 1140909-48-3 Raw Materials Powder
    • Cabozantinib Malate CAS 1140909-48-3 Raw Materials Powder
    • Cabozantinib Malate CAS 1140909-48-3 Raw Materials Powder storehouse
    • Cabozantinib Malate CAS 1140909-48-3 Raw Materials Powder quality testing
    • Cabozantinib Malate CAS 1140909-48-3 Raw Materials Powder quality testing
    • Cabozantinib Malate CAS 1140909-48-3 Raw Materials Powder certificate

    Product Overview:

    Cabozantinib Malate Powder is a small molecule C-Met modulator. Cabozantinib malate acts as a potent multi-target VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50s of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively.Cabozantinib Malate CAS 1140909-48-3 showed dose-dependent inhibition of tumor growth and tumor regression associated with disruption of the tumor vascular system and extensive tumor apoptosis.Cabozantinib Malate Raw Materials primarily targets MET and VEGFR2 tyrosine kinases associated with prostate cancer growth and proliferation, inhibiting tumor metastasis and vascular The main target of Cabozantinib Malate Raw Materials is MET and VEGFR2 tyrosine kinases, which are associated with prostate cancer growth and proliferation, to inhibit tumor metastasis and angiogenesis.

    Cabozantinib Malate CAS 1140909-48-3 Raw Materials Powder Attributes

    Cabozantinib Malate CAS 1140909-48-3 Raw Materials Powder

    CAS: 1140909-48-3

    MF:  C32H30FN3O10

    Cabozantinib Malate

    MW:  635.6

    EINECS: 691-711-0

    Specification​: 99% min Cabozantinib Malate

    Sample: Cabozantinib Malate Powder

    Brand: Henrikang

    Appearance: White Powder

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Portal:https://henrikang.en.made-in-china.com/

    Cabozantinib Malate CAS 1140909-48-3 Raw Materials Powder Details

    Cabozantinib Malate Powder Usage and Synthesis.

    Cabozantinib Malate Powder is a small molecule C-Met modulator. Cabozantinib malate acts as a potent multi-target VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50s of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively.

    Cabozantinib Malate CAS 1140909-48-3 showed dose-dependent inhibition of tumor growth and tumor regression associated with disruption of the tumor vascular system and extensive tumor apoptosis.

    Cabozantinib Malate Raw Materials primarily targets MET and VEGFR2 tyrosine kinases associated with prostate cancer growth and proliferation, inhibiting tumor metastasis and vascular The main target of Cabozantinib Malate Raw Materials is MET and VEGFR2 tyrosine kinases, which are associated with prostate cancer growth and proliferation, to inhibit tumor metastasis and angiogenesis.

    Cabozantinib Malate Powder

    Application/Function of Cabozantinib Malate Powder.

    Cabozantinib Malate was developed by Exelixis Biopharmaceuticals, Inc. It targets MET and VEGFR2 tyrosine kinases, which are associated with the growth and spread of prostate cancer, to inhibit tumor metastasis and angiogenesis.

    Cabozantinib Malate Powder

    Pharmacological effect of Cabozantinib Malate Powder

    CabozantinibS-MALATE, formerly known as XL184, was developed by Exelixis Biopharmaceuticals, Inc. It targets MET and VEGFR2 tyrosine kinases, which are associated with the growth and spread of prostate cancer, to inhibit tumor metastasis and angiogenesis.

    Cabozantinib malate, the malate salt of Cabozantinib, is a potent VEGFR2 inhibitor with an IC50 of 0.035nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2 and AXL with IC50s of 1.3nM, 4nM, 4.6nM, 12nM/11.3nM/6nM, respectively. 14.3nM and 7nM.

    Cabozantinib Malate Powder

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,